Bank Of New York Mellon Corp Codex Dna, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.8 - $6.45 $31,152 - $111,630
-17,307 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$4.12 - $10.36 $2,698 - $6,785
655 Added 3.93%
17,307 $93,000
Q4 2021

Feb 11, 2022
BUY
$6.31 - $11.96 $15,850 - $30,043
2,512 Added 17.77%
16,652 $180,000
Q3 2021

Nov 12, 2021
BUY
$10.15 - $19.88 $143,521 - $281,103
14,140 New
14,140 $157,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email